Intel Raises Dividend – Analyst Blog
Zacks Market Commentaries (November 17th, 2009) Writes:
Zacks Market Commentaries (November 17th, 2009) Writes:
Zacks Market Commentaries (November 16th, 2009) Writes:
Zacks Market Commentaries (November 13th, 2009) Writes:
Zacks Market Commentaries (November 4th, 2009) Writes:
Zacks Market Commentaries (October 20th, 2009) Writes:
With buyers back in action, US stocks rose to their fresh one-year highs and remained near their high points as optimism grew that an economic recovery, helped by solid third-quarter earnings reports and increased M&A activity, is on cards.
The Dow Jones industrial average rose 96.28 points, or 0.96%, to close at 10,092.19. The broader S&P 500 index jumped 10.23 points, or 0.94%, to 1,097.91 and the tech-heavy Nasdaq climbed 19.52 points, or 0.91%, to 2,176.32, its highest point since September 26, 2008. Market breadth was positive, with advancing shares ahead of decliners by a margin of three-to-one. Only five of the DJIA thirty declined in price.
After the close, iPhone maker Apple Inc. (NASDAQ:AAPL) and Texas Instruments (NYSE:TXN) reported better-than-estimated numbers, fuelling hopes for the technology industry. Last week Google Inc. (NASDAQ:GOOG) and Intel Corp’s (NASDAQ:INTC) numbers had come in above expectations.
Although there were some jitters last
...
Zacks Market Commentaries (October 19th, 2009) Writes:
For Immediate Release
Chicago, IL – October 19, 2009 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: International Business Machine (IBM), Accenture (ACN), Intel Corp. (INTC), Google Inc. (GOOG) and Advanced Micro Devices (AMD).
Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: http://at.zacks.com/?id=5513
Here are highlights from Friday’s AnalystBlog:
IBM Exceeds & Raises Outlook
International Business Machine’s (IBM) third-quarter 2009 earnings exceeded the Zacks Consensus Estimate by one cent. As a result of expense management, net profit improved by 14% to $3.2 billion, while earnings per share rose 18% to $2.40 per share. This compares to
...
Zacks Market Commentaries (October 16th, 2009) Writes:
Zacks Market Commentaries (October 15th, 2009) Writes:
For Immediate Release
Chicago, IL – October 15, 2009 – Zacks Equity Research highlights Sangamo Biosciences, Inc. (SGMO) as the Bull of the Day and Conmed (CNMD) the Bear of the Day. In addition, Zacks Equity Research provides analysis on Intel Corp. (INTC), JPMorgan Chase & Company (JPM) and CSX Corp. (CSX).
Full analysis of all these stocks is available at http://at.zacks.com/?id=2676
Here is a synopsis of all five stocks:
Sangamo Biosciences, Inc. (SGMO) uses a proprietary ZFP gene regulation technology to discover and develop a new class of therapeutic candidates for diabetic neuropathy, cardiovascular disease, cancer and immune diseases.
We are optimistic about this novel technology. SB-509 has shown some positive results for the treatment of moderate to severe DN. We are also optimistic about other clinical programs. Further, we are impressed by the company's strategy
...
Zacks Market Commentaries (October 14th, 2009) Writes:
Zacks Market Commentaries (October 14th, 2009) Writes:
Xilinx Inc. (XLNX) is expected to report its second quarter results later today. Last month, the company had upgraded its guidance for the quarter. It expects quarterly sales to be up approximately 10% sequentially due to the broad based strength across all end markets and geographical divisions. Xilinx expects to ship most of last quarter’s delinquencies in the September quarter. Management reiterated its gross margin guidance of 61%. Operating expenses are estimated to come around $175 million, including $5 million in restructuring charges. California-based Xilinx designs and manufactures a broad range of high-performance, high-density programmable logic devices (PLDs) for electronic equipment manufacture. Earlier, rival Altera Corp. (ALTR) reported its quarterly results that matched expectations. Sales of $286.6 million were down 20% from a year ago but up 3% sequentially. Management stated that business conditions improved steadily during the quarter and most markets performed better than
...